Loading...
Vivani Medical Inc (VANI) is not a strong buy for a beginner investor with a long-term strategy at this time. While insider buying is a positive signal, the company's financial performance is weak, with no revenue growth and negative net income. Additionally, technical indicators and options data do not suggest significant upward momentum. Given the lack of strong positive catalysts and the absence of Intellectia Proprietary Trading Signals, holding off on investment is recommended.
The MACD histogram is negative and contracting (-0.00566), indicating weak momentum. RSI is neutral at 54.947, and moving averages are converging, showing no clear trend. Key resistance levels are at 1.319 and 1.361, with support at 1.181 and 1.139. Overall, the technical indicators suggest a lack of strong directional movement.

Insider buying has increased significantly by 16092.41% over the last month, which is a positive signal.
The company has no revenue growth, negative net income, and no recent news or event-driven catalysts. Additionally, the stock trend analysis shows a likelihood of slight declines in the next week and month.
In Q3 2025, the company reported no revenue growth (0% YoY), negative net income of -$6.53 million (up 8.09% YoY), and an EPS of -0.11 (0% YoY). Gross margin remains at 0%. Overall, the financials indicate poor performance with no signs of growth.
No analyst ratings or price target changes are available for this stock.